title: Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle.
abstract: Overstimulation of endothelin type A (ET(A)) and nucleotide (P2Y) Gα(q)-coupled receptors in vascular smooth muscle causes vasoconstriction, hypertension, and, eventually, hypertrophy and vascular occlusion. G protein-coupled receptor kinases (GRKs) and arrestin proteins are sequentially recruited by agonist-occupied Gα(q)-coupled receptors to terminate phospholipase C signaling, preventing prolonged/inappropriate contractile signaling. However, these proteins also play roles in the regulation of several mitogen-activated protein kinase (MAPK) signaling cascades known to be essential for vascular remodeling. Here we investigated whether different arrestin isoforms regulate endothelin and nucleotide receptor MAPK signaling in rat aortic smooth muscle cells (ASMCs). When intracellular Ca(2+) levels were assessed in isolated ASMCs loaded with Ca(2+)-sensitive dyes, P2Y(2) and ET(A) receptor desensitization was attenuated by selective small-interfering (si)RNA-mediated depletion of G protein-coupled receptor kinase 2 (GRK2). Using similar siRNA techniques, knockdown of arrestin2 prevented P2Y(2) receptor desensitization and enhanced and prolonged p38 and ERK MAPK signals, while arrestin3 depletion was ineffective. Conversely, arrestin3 knockdown prevented ET(A) receptor desensitization and attenuated ET1-stimulated p38 and ERK signals, while arrestin2 depletion had no effect. Using Transwell assays to assess agonist-stimulated ASMC migration, we found that UTP-stimulated migration was markedly attenuated following arrestin2 depletion, while ET1-stimulated migration was attenuated following knockdown of either arrestin. These data highlight a differential arrestin-dependent regulation of ET(A) and P2Y(2) receptor-stimulated MAPK signaling. GRK2 and arrestin expression are essential for agonist-stimulated ASMC migration, which, as a key process in vascular remodeling, highlights the potential roles of GRK2 and arrestin proteins in the progression of vascular disease.
authors.affiliation: Dept. of Cancer Studies and Molecular Medicine, Leicester Royal Infirmary, Leicester, UK.
authors.forename: Gavin E
authors.initials: GE
authors.lastname: Morris
authors.forename: Carl P
authors.initials: CP
authors.lastname: Nelson
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Brighton
authors.forename: Nicholas B
authors.initials: NB
authors.lastname: Standen
authors.forename: R A John
authors.initials: RA
authors.lastname: Challiss
authors.forename: Jonathon M
authors.initials: JM
authors.lastname: Willets
mesh_terms: D000818:Animals; D019390:Arrestins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D001158:Arteries / Q000378:metabolism; D002118:Calcium / Q000032:analysis; D002465:Cell Movement / Q000502:physiology; D016257:Fura-2 / Q000031:analogs & derivatives / Q000032:analysis; D054769:G-Protein-Coupled Receptor Kinase 2 / Q000378:metabolism; D055785:Gene Knockdown Techniques; D006973:Hypertension / Q000378:metabolism*; D008297:Male; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D032389:Myocytes, Smooth Muscle / Q000737:chemistry / Q000378:metabolism; D010766:Phosphorylation; D034741:RNA, Small Interfering / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D044022:Receptor, Endothelin A / Q000378:metabolism*; D058473:Receptors, Purinergic P2Y2 / Q000378:metabolism*; D015398:Signal Transduction; D010738:Type C Phospholipases / Q000378:metabolism
chemical_list: D019390:Arrestins; D034741:RNA, Small Interfering; D044022:Receptor, Endothelin A; D058473:Receptors, Purinergic P2Y2; C082333:arrestin3; C049925:fura-2-am; D054769:G-Protein-Coupled Receptor Kinase 2; D020928:Mitogen-Activated Protein Kinases; D010738:Type C Phospholipases; D002118:Calcium; D016257:Fura-2